Affiliation:
1. University Hospital; Federal University of Minas Gerais, Brazil
Abstract
Clozapine has been used as an attempt to manage levodopa complications in advanced Parkinson's disease (PD). To investigate the use of clozapine in this context in a Brazilian sample, a retrospective chart review was carried out at the Movement Disorders Clinic from the Federal University of Minas Gerais. This study enrolled 43 PD patients who used or were in use of clozapine. Patients had a mean age of 64 years and a mean UPDRS score of 55. Clozapine was indicated for dyskinesias in 17 patients, for psychosis in 15 and for both reasons in 11. The average maximum dose was 70 mg/day. Twenty six patients used it for a mean of 3.5 years. Twenty nine presented an improvement of their condition, 9 remained clinically stable. Twenty subjects interrupted the use of clozapine, being 9 due to adverse effects. Clozapine may play a role in the management of motor and psychiatric complications in PD, but it is associated with low tolerability.
Subject
Neurology,Neurology (clinical)
Reference19 articles.
1. Treatment of advanced Parkinson's disease;Diamond A;Expert Rev Neurother,2006
2. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis;Frieling H;Eur Neuropsychopharmacol,2007
3. Atypical antipsychotics in the EPS-vulnerable patient;Friedman JH;Psychoneuroendocrinology,2003
4. Atypical antipsychotics in Parkinson-sensitive populations;Friedman JH;J Geriatr Psychiatry Neurol,2002
5. Long-term outcome of clozapine use for psychosis in parkinsonian patients;Fernandez HH;Mov Disord,2004
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献